Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet

A Dendritic Cell Primer for Oncology Nurses

Elaine S. DeMeyer
Patricia C. Buchsel
CJON 2005, 9(4), 460-464 DOI: 10.1188/05.CJON.460-464

Once believed to be part of the nervous system, dendritic cells (DCs) now are known to be potent antigen-presenting cells of the immune system. Upon capturing a foreign antigen, the immature DC matures as it travels to the T cells to activate an immune response. DCs can be categorized into two main subsets: DC1s and DC2s. DC1s, also called myeloid-related DCs, arise from early-precursor cells or monocytes and play a role in initiating immune responses against antigens such as cancer cells. Various cytokines stimulate the growth and differentiation of DCs, such as granulocyte macrophage-colony-stimulating factor. DC research is evolving rapidly as a clinical therapy; therefore, nurses should appreciate the cell's mechanisms of action.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or